SPC497
Fidanacogen elaparvovec
Status:
UmsóknApplication date:
21.1.2025Application published:
15.2.2025
Medicine name:
Durveqtix / BeqvezMedicine for children:
No
Timeline
Today
21.1.2025Application
15.2.2025Publication
Marketing license
Foreign authorization number:
EU/1/24/1838Date:
24.7.2024
Owner
Name:
uniQure biopharma B.V.Address:
Paasheuvelweg 25a, 1105 BP Amsterdam NL
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113 Reykjavík
Patent
Number:
EP3581650